Literature DB >> 1790643

The effects of peripheral cold exposure on oesophageal motility in patients with autoimmune rheumatic diseases and Raynaud's phenomenon.

E V Tsianos1, C Berecos, E Stavropoulos, E Kazazis, I C Danielides, A A Drosos.   

Abstract

The effects of peripheral cold exposure on oesophageal motility were studied in 14 patients with autoimmune rheumatic diseases. They were divided into two groups: 9 with and 5 without Raynaud's phenomenon. The statistical comparison of these two groups did not reveal any difference in the way they manometrically reacted during and after the cold exposure. We conclude that the oesophageal dysfunction in Raynaud's phenomenon may not be of neurogenic origin.

Entities:  

Mesh：

Year:  1991        PMID： 1790643     DOI： 10.1007/bf02208697

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  9 in total

1.  APERISTALSIS OF THE ESOPHAGUS IN PATIENTS WITH CONNECTIVE-TISSUE DISORDERS AND RAYNAUD'S PHENOMENON.

Authors:  M B STEVENS; P HOOKMAN; C I SIEGEL; J R ESTERLY; L E SHULMAN; T R HENDRIX
Journal:  N Engl J Med       Date:  1964-06-04       Impact factor: 91.245

2.  Oesophageal ischaemia in motility disorders associated with chest pain.

Authors:  J MacKenzie; J Belch; D Land; R Park; J McKillop
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

3.  Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.

Authors:  T J Poirier; G B Rankin
Journal:  Am J Gastroenterol       Date:  1972-07       Impact factor: 10.864

4.  The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease.

Authors:  S Cohen; R Fisher; W Lipshutz; R Turner; A Myers; R Schumacher
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

5.  Esophageal dysfunction and Raynaud's phenomenon in patients with scleroderma.

Authors:  A L Hurwitz; A Duranceau; R W Postlethwait
Journal:  Am J Dig Dis       Date:  1976-08

6.  Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

Authors:  E L Alexander; G S Firestein; J L Weiss; R R Heuser; G Leitl; H N Wagner; J A Brinker; A A Ciuffo; L C Becker
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

7.  Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus.

Authors:  F Gutierrez; J E Valenzuela; G R Ehresmann; F P Quismorio; R C Kitridou
Journal:  Dig Dis Sci       Date:  1982-07       Impact factor: 3.199

8.  Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon.

Authors:  A G Tzioufas; Y A Dalavanga; S H Constantopoulos; E B Tsianos; C Papadimitriou; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  1985 Jul-Sep       Impact factor: 4.473

9.  Oesophageal dysfunction in patients with primary Sjögren's syndrome.

Authors:  E B Tsianos; C D Chiras; A A Drosos; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103
  9 in total
  1 in total

1.  Increased capillary permeability in systemic sclerosis: help or hindrance?

Authors:  W Grassi; P Core; C Cervini
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.